~~<i id='282096E7AF'><strike id='282096E7AF'><tt id='282096E7AF'><pre id='282096E7AF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：focus 2025-09-30 18:55:06 - browse：75332

Exterior photo of UnitedHealth Group building — Courtesy UnitedHealth Group

UnitedHealth Group has about 90,000 employed or affiliated doctors, approximately 10% of all physicians in the U.S.

The number — disclosed Wednesday at the company’s investor day by Amar Desai, the CEO of UnitedHealth’s Optum Health division — means the company acquired or hired 20,000 doctors in the past year alone.

The rapid growth of UnitedHealth’s physician base underscores how the company, which already is the country’s largest private health insurer, is looking to control more of the health care delivery system, and how this growth is going unchecked by antitrust agencies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： An inside look at PIPEs, biotech's buzzy new financing tool

Wikipedia

knowledge

hotspot

Wikipedia

explore

Wikipedia

1:44TheU.S.CapitolBuildingisshownonAug.1,2023inWashington.AnnaMoneymaker/GettyImagesAratingagencydow

WSS

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

International team creates first chimeric human

Amazon expands telehealth clinic nationwide

Flu vaccine offering decent levels of protection this winter, new data show

National panel will explore requiring free Covid tests

entertainment

fashion

Wikipedia

Medicare details structure of new drug price negotiation program

Biotech companies concerned about China biosecurity crackdown

Drug repurposing or repositioning? The language matters

International team creates first chimeric human

Jerome Adams on the need for new antivirals for Covid

Covid isolation guidance eased by the CDC

State Dept. review finds Biden bears some blame for Afghanistan failures

Pfizer highlights cancer drugs it thinks could reignite investor interest

Medicare details structure of new drug price negotiation program

ALS groups 'won't be played again' by the FDA, drug sponsors

knowledge

ALS groups 'won't be played again' by the FDA, drug sponsors

The high personal cost of affirmative action for Black doctors

An inside look at PIPEs, biotech's buzzy new financing tool

Why getting cancer drugs just got harder for rural patients

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Pfizer highlights cancer drugs it thinks could reignite investor interest

hotspot

Wikipedia

explore

Wikipedia